Continuous Positive Airway Pressure Devices Market 2016-2020 Covering: A detailed analysis of the positive airway pressure devices market by product type, including CPAP devices and accessories and by geography (the Americas, APAC, and EMEA). The report also covers the present scenario and the growth prospects of this market and highlights the key vendors, namely ResMed, Philips Healthcare, and Fisher & Paykel.
Market outlook of the continuous positive airway pressure devices market Continuous positive airway pressure therapy is the most common treatment for obstructive sleep apnea that uses continuous mild air pressure. These devices are used to keep the airways open during sleep and also to control the output pressure keeping the airflow pressure constant. The global continuous positive airway pressure devices market is just budding and offers high growth opportunity, and hence is expected to progress with steady growth, posting a CAGR of nearly 7% during the forecast period.
One of the major drivers of the market is high prevalence of sleep disorders. It is estimated that over 350 million people worldwide suffer from sleep apnea. Thus, the increasing awareness of sleep apnea and associated comorbid conditions such as high blood pressure, and obesity have led to increased demand for sleep apnea diagnostic and therapeutic devices. Similarly, advances in technology such as improved mask design, oral appliances, and use of oxygen devices are expected to provide support to continuous positive airway pressure users.
Segmentation by product type and analysis of - CPAP devices and accessories A CPAP device is used to maintain a continuous level of PAP and is used to treat preterm babies whose lungs have not yet fully developed. CPAP devices comply with all age groups and are cost-effective, simple, and easy to use. This segment dominated the market with total market share of nearly 56% in 2015.
This report offers an analysis of each of the following segments and discusses its impact on the overall market growth – - Continuous positive airway pressure (CPAP) devices - Accessories
Geographical segmentation and analysis of - Americas, APAC, EMEA The continuous positive airway pressure devices market is currently dominated by the Americas, accounting for a market share of almost 59%, followed by the EMEA region and the APAC region. In the Americas, the US was the largest revenue contributor because of the increased diagnosis of sleep apnea in patients.
This report offers an analysis of each of the following segments and discusses its impact on the overall market growth - - Americas - APAC - EMEA
Competitive landscape and key vendors - The majority of the continuous positive airway pressure devices market is dominated by reputed international vendors while the remaining market is fragmented. The dominating vendors compete among each other based on factors such as product features, price and reliability. However, the emerging players are developing innovative devices to treat obstructive sleep apnea (OSA) and other sleep related respiratory conditions, which could pose a threat to major vendors in terms of revenue and sales.
The top vendors in the market are - - ResMed - Philips Healthcare - Fisher & Paykel
Key questions answered in the report include - What will the market size and the growth rate be in 2020? - What are the key factors driving the global continuous positive airway pressure devices market 2016-2020? - What are the key market trends impacting the growth of the global continuous positive airway pressure devices market 2016-2020? - What are the challenges to market growth? - Who are the key vendors in the global continuous positive airway pressure devices market 2016-2020? - What are the market opportunities and threats faced by the vendors in the global continuous positive airway pressure devices market 2016-2020? - What are the trending factors influencing the market shares of the APAC, EMEA, and the Americas? - What are the key outcomes of the five forces analysis of the global continuous positive airway pressure devices market 2016-2020?
Technavio also offers customization on reports based on specific client requirement.
Related reports - Global Respiratory Devices Market 2014-2018 - Global Pressure Relief Devices Market 2015-2019 - Global Coronary Artery Disease Treatment Devices Market 2015-2019 - Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019 - Global Hyperbaric Oxygen Therapy Devices Market: Industry Analysis 2015-2019
Our reports have been used by over 10K customers, including:
The sleep apnea devices market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period. Market growth is mainly driven by factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral...
The Global Nasal Cannula Market size is expected to reach $7.9 billion by 2027, rising at a market growth of 4% CAGR during the forecast period. The nasal cannula refers to medical equipment which is used to provide oxygen to people when they are unable to get a sufficient amount of oxygen for optimum body functioning. This condition arises...
Scope of the Report The report titled “Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in-depth analysis of the global respiratory care medical devices market with description of market sizing and growth. The analysis includes market by value and market share by...
The respiratory ventilator tester market was valued at US$ 148.00 million in 2019 and is projected to reach US$ 199.20 million by 2027; it is expected to grow at a CAGR of 3.8% from 2020 to 2027. The growth of the market is mainly attributed to factors such as growing prevalence of respiratory diseases and increasing geriatric population....
The Asia Pacific pulmonary devices market is expected to reach US$ 8,196.82 million by 2027 from US$ 3,661.53 million in 2019. The market is estimated to grow at a CAGR of 10.6 % during 2019–2027. The growth of the pulmonary devices market in Asia Pacific is attributed to the increasing prevalence of respiratory diseases and growing...
200 pages •
By The Business Research Company
• Sep 2020
Major players in the respiratory devices and equipment (therapeutic and diagnostic) market are Smiths Medical, Philips Healthcare, GE Healthcare, Chart Industries and Invacare Corporation. The global respiratory devices and equipment (therapeutic and diagnostic) market is expected to grow from $13.6 billion in 2019 to $22.2 billion...
The global respiratory care devices market is expected to reach nearly US$ 35 Billion by 2026. Respiratory care is a healthcare specialty, which is focused on improving cardiopulmonary functions and promoting health & wellness. Respiratory care devices are used for the diagnosis, treatment, and monitoring of patients who are suffering from...
The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019. The market is estimated to grow at a CAGR of 10.3% during 2019–2027. The growth of the pulmonary devices market in North America is attributed to the increasing prevalence of respiratory diseases and growing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Respiratory Inhalers Market Report The respiratory inhalers market by revenue is expected to grow at a CAGR of over 9% during the period 2019–2025. The global respiratory inhalers market is one of the steadily growing segments in...
Chronic Obstructive Pulmonary Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.